• Product NameChloropyramine hydrochloride
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityChloropyramine is a first generation antihistamine drug approved in some Eastern European countries for the treatment of allergic conjunctivitis, allergic rhinitis, bronchial asthma, and other atopic (allergic) conditions. Related indications for clinical use include Quinckes edema, allergic reactions to insect bites, food and drug allergies, and anaphylactic shock.
• Target NameFAK; Histamine Receptor antagonist
• CAS No. 6170-42-9
• Calculated MW 326.26
• Formulation C16H20ClN3HCl
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:Cl.CN(C)CCN(CC1=CC=C(Cl)C=C1)C1=CC=CC=N1
  Pathways:GPCR/G Protein; Angiogenesis; Cytoskeletal Signaling; Immunology/Inflammation; Neuroscience
  Receptor:FAK-VEGFR-3; H1 receptor
  Boling pt:413.5C
  Melting pt:168-172C
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Budihna M, et al. Pflugers Arch. 1996;431(6 Suppl 2):R217-8.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting